The Diagnostic Imaging CT modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of CT across the healthcare continuum, from various cancer screenings, such as lung and colon, to cardiothoracic imaging, to appendicitis, and more.
November 20th 2024
While a large retrospective study found that interstitial lung abnormalities (ILAs) were evident on 1.7 percent of computed tomography (CT) scans, researchers found that 43.9 percent of ILAs, including fibrotic ILAs, were not reported.
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
Annual Hawaii Cancer Conference
January 25-26, 2025
Register Now!
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
Terrorist threat intensifies nuclear medicine’s “image” problem
October 9th 2006It should come as no shock that the word “nuclear” conjures negative reactions. This is why nuclear magnetic resonance imaging was abridged decades ago and may be why the Society of Nuclear Medicine lately prefers its acronym and a slogan steeped in molecular imaging.
GE seeks industry support for CT injector standard
October 6th 2006Most CT equipment forces technologists to turn into contortionists when techs administer CT contrast. With one hand on the scanner console and the other on the power injector key pad, the tech attempts to trigger the scan and injection simultaneously. Most of the time it works, but the process could be a lot easier and more productive.
The multimodality revolution offers business opportunities for vendors
September 18th 2006Hard though it is to believe, there is another issue facing outpatient imaging centers besides the Deficit Reduction Act, information technology, and turf wars. It’s the multimodality revolution, which encompasses plain film x-ray, ultrasound, and yes, even mammography.
In vitro test guides follow-up studies
September 14th 2006Underlying the appeal of personalized medicine is the link between in vitro and in vivo testing. The hope is that laboratory studies run on samples of body fluids will spot the earliest signs of disease, providing physicians with guidance on what to look for and where with imaging modalities.
The future of total service ranks a ‘high five’
September 1st 2006When discussing the importance of understanding your competition, we used a tool known as the High 5. The High 5 provides a company with the best approach to servicing customers. By knowing the five key factors a customer would use to select between competitors, and providing the best response to each, a company puts itself in the win position.
Philips focuses on computing power to pave way for advances
August 28th 2006Advances in computing power will reshape medical imaging, allowing the merger of diagnostic and therapeutic methods, according to Diego Olego, chief technology officer for Philips Medical Systems. The result will be expanded diagnostic applications and increased precision in targeting pathology for therapy.
Nuc med society modifies name, emphasizes molecular imaging
August 28th 2006The Society of Nuclear Medicine has shed its full name in favor of its acronym and a new tagline: “SNM: Advancing Molecular Imaging and Therapy.” The modification comes amid rapid changes in technology, therapy, and imaging. Diagnostic Imaging asked SNM president Dr. Martin Sandler to talk about the transformation.
Optical technology sheds light on prostate imaging
August 22nd 2006Imulux, a pioneer in optical coherence tomography, showcased its FDA-cleared technology, Niris, at the World Congress of Endourology in Cleveland last week. Unlike other optical imaging tools that focus on the breast or brain, Niris renders images of the prostate. The system achieves a spatial resolution of 0.01 mm, which is well beyond the reach of diagnostic ultrasound.
Toshiba allies with McKesson on CT mini-PACS
August 21st 2006Two IT products designed by McKesson have found their way into Toshiba America Medical Systems’ CT portfolio. The CT-specific mini-PACS products support Toshiba’s flagship Aquilion scanner. One is a low-cost archive for cardiology and the other is a scaled-down radiology PACS.
Breast CT scanner nears readiness for commercial market
July 27th 2006A breast CT scanner dedicated to diagnostic applications could be on the market by the end of this year. The clinical test unit, unveiled today at the University of Rochester Medical Center, NY, has already scanned several patients and will soon begin a 60-patient study to compare its images with those obtained using conventional mammography systems.
Signs of turf war over cardiac CT appear at SCCT meeting
July 26th 2006The truce over cardiac CT between cardiologists and radiologists showed signs of strain last week at the Society of Cardiovascular Computed Tomography meeting in Washington, DC, when several radiologists charged that the endorsement of clinical guidelines by the society favored cardiologists.
JAMA publication confirms utility of coronary CTA
July 25th 2006Sixteen-slice CT angiography can rule out -- but cannot conclusively identify -- heart disease in patients, according to results to be published in tomorrow’s issue of the Journal of the American Medical Association. The results establish a baseline for expectations regarding higher performance CTs, as their faster scan times could provide even better results.